Perbedaan Merck Tbk. dan Sat Nusapersada Tbk: Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb), sedangkan Sat Nusapersada Tbk diperdagangkan di Rp248 (kapitalisasi pasar 1,3 T, volume 24 jam 291,8 rb). Perbedaan utamanya: Merck Tbk. lebih besar dari sisi kapitalisasi pasar, dan Sat Nusapersada Tbk lebih aktif diperdagangkan (291,8 rb vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MERK | PTSN | |
|---|---|---|
Kapitalisasi Pasar | 1,7 T | 1,3 T |
Volume | 37,6 rb | 291,8 rb |
Lot | 376 | 2,92 rb |
Perputaran | 144,47 jt | 71,98 jt |
Harga Rata-rata | 3.842,23 | 246,69 |
Nilai Transaksi | 144,47 jt | 71,98 jt |
Harga Ekuilibrium Indikatif | 3.840 | 248 |
Volume Ekuilibrium Indikatif | 7 | 23 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →Sat Nusapersada Tbk (the company) was established on Jun 1, 1990 based on Notaries Deed No. 5 and the deed of establishment was approved by the the Ministry of Justice dated Sept 18, 1991. The Company’s articles of association has been amended several times, most recently by notarial deed No. 14 of Fathiah Helmi, S.H., dated Aug 7, 2007, concerning public offering.
Selengkapnya di halaman PTSN →